Common Cold
Conditions
Interventions
experimental group:Cuitang Granules
placebo group:Cuitang Granule Simulator
Positive drug group:Cuitang Pill
Sponsors
Beijing Hospital of Traditional Chinese Medicine affiliated to Capital Medical Universit
Eligibility
Sex/Gender
Male
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) According to the diagnosis of common cold; (2) Body temperature (under axilla) 37.5 to 39.0 degree C at the time of consultation; (3) The course of cold is within 48 hours; (4) TCM syndrome differentiation is wind-cold and internal heat syndrome; (5) Aged 18-65 years old; (6) those who voluntarily sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) The total number of white blood cells in blood routine examination > 11.0 *10^9/L, or the percentage of neutrophils > 80%, or CRP exceeding the upper limit of reference value; (2) Influenza was diagnosed; (3) Patients with acute episodes of upper respiratory tract diseases such as sinusitis, allergic rhinitis, chronic pharyngitis, tonsillitis, herpes angina were diagnosed; (4) Complicated with lower respiratory tract infection (such as pneumonia, acute, chronic bronchitis, bronchiectasis); (5) During the course of the disease, those who had taken antibiotics or traditional Chinese medicine or other Western medicines for treating colds before admission to the group; (6) Patients with malignant tumors complicated with serious primary diseases such as heart, lung, brain and hematopoietic system; (7) Drug allergies to test drugs, including those who have allergic history to the ingredients of the product, paracetamol or pharmaceutical excipients; (8) Women in pregnancy or planned pregnancy, breast-feeding women, who are unable or unwilling to take adequate contraception during the trial or whose spouses are unwilling to take contraceptive measures; (9) Psychiatric subjects and those unable to cooperate with clinical trials; (10) Those who have participated in other clinical trials or are participating in other drug clinical trials in the past four weeks; (11) Doctors do not consider it appropriate to participate in clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 24 hour antipyretic rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Onset time of antipyretic;Body temperature recovery time;Improvement of main clinical symptoms (cough, headache, joint soreness);Clinical curative effect of cold;TCM syndrome curative effect;Administration of paracetamol tablets; | — |
Countries
China
Contacts
Public ContactQingquan Liu
Beijing hospital of traditional Chinese medicine affiliated to capital medical university
Outcome results
None listed